Damora Therapeutics, Inc.
DMRA
$31.04
$0.311.01%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 540.52M | 532.90M | 257.62M | 7.61M | 10.21M |
| Total Receivables | 880.00K | 894.00K | 899.00K | 992.00K | 988.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 243.00K | 410.00K | 577.00K | 56.00K | 232.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.95M | 1.21M | 1.32M | 1.13M | 1.60M |
| Total Current Assets | 543.59M | 535.41M | 260.42M | 9.79M | 13.03M |
|
|
|||||
| Total Current Assets | 543.59M | 535.41M | 260.42M | 9.79M | 13.03M |
| Net Property, Plant & Equipment | -- | -- | 104.00K | 113.00K | 122.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 48.00K | 34.00K | -- | 837.00K | 542.00K |
| Total Assets | 543.64M | 535.44M | 260.53M | 10.74M | 13.69M |
|
|
|||||
| Total Accounts Payable | 3.48M | 819.00K | 17.67M | 520.00K | 756.00K |
| Total Accrued Expenses | 13.34M | 4.34M | 719.00K | 1.72M | 1.42M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 15.00K | 15.00K | 15.00K |
| Total Finance Division Other Current Liabilities | 10.72M | 18.66M | 1.67M | 372.00K | 437.00K |
| Total Other Current Liabilities | 10.72M | 18.66M | 1.67M | 372.00K | 437.00K |
| Total Current Liabilities | 27.55M | 23.81M | 20.07M | 2.62M | 2.63M |
|
|
|||||
| Total Current Liabilities | 27.55M | 23.81M | 20.07M | 2.62M | 2.63M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 53.00K | 57.00K | 60.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 27.00K | 27.00K | 28.00K | 49.00K | 49.00K |
| Total Liabilities | 27.58M | 23.84M | 20.15M | 2.73M | 2.74M |
|
|
|||||
| Common Stock & APIC | 931.65M | 893.54M | 310.69M | 292.47M | 292.30M |
| Retained Earnings | -546.32M | -515.15M | -487.36M | -286.63M | -283.49M |
| Treasury Stock & Other | 732.00K | 754.00K | 802.00K | 823.00K | 809.00K |
| Total Common Equity | 386.06M | 379.15M | -175.87M | 6.67M | 9.61M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 130.00M | 132.45M | 416.25M | 1.34M | 1.34M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 130.00M | 132.45M | 416.25M | 1.34M | 1.34M |
|
|
|||||
| Total Common Equity | 386.06M | 379.15M | -175.87M | 6.67M | 9.61M |
| Total Preferred Equity | 130.00M | 132.45M | 416.25M | 1.34M | 1.34M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 516.06M | 511.60M | 240.38M | 8.01M | 10.95M |
|
|
|||||